Asfour, S.S.; Alshaikh, B.; AlMahmoud, L.; Sumaily, H.H.; Alodhaidan, N.A.; Alkhourmi, M.; Abahussain, H.A.; Khalil, T.M.; Albeshri, B.A.; Alhamidi, A.A.;
et al. SMOFlipid Impact on Growth and Neonatal Morbidities in Very Preterm Infants. Nutrients 2022, 14, 3952.
https://doi.org/10.3390/nu14193952
AMA Style
Asfour SS, Alshaikh B, AlMahmoud L, Sumaily HH, Alodhaidan NA, Alkhourmi M, Abahussain HA, Khalil TM, Albeshri BA, Alhamidi AA,
et al. SMOFlipid Impact on Growth and Neonatal Morbidities in Very Preterm Infants. Nutrients. 2022; 14(19):3952.
https://doi.org/10.3390/nu14193952
Chicago/Turabian Style
Asfour, Suzan S., Belal Alshaikh, Latifah AlMahmoud, Haider H. Sumaily, Nabeel A. Alodhaidan, Mousa Alkhourmi, Hissah A. Abahussain, Thanaa M. Khalil, Bushra A. Albeshri, Aroub A. Alhamidi,
and et al. 2022. "SMOFlipid Impact on Growth and Neonatal Morbidities in Very Preterm Infants" Nutrients 14, no. 19: 3952.
https://doi.org/10.3390/nu14193952
APA Style
Asfour, S. S., Alshaikh, B., AlMahmoud, L., Sumaily, H. H., Alodhaidan, N. A., Alkhourmi, M., Abahussain, H. A., Khalil, T. M., Albeshri, B. A., Alhamidi, A. A., Al-Anazi, M. R., Asfour, R. S., & Al-Mouqdad, M. M.
(2022). SMOFlipid Impact on Growth and Neonatal Morbidities in Very Preterm Infants. Nutrients, 14(19), 3952.
https://doi.org/10.3390/nu14193952